Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.24.1.1.u2
Income Taxes
12 Months Ended
Mar. 31, 2022
Income Taxes  
Income Taxes

9. Income Taxes

Loss before provision for income taxes consisted of the following for the years ended March 31, 2022 and 2021 (in thousands):

Year Ended March 31,

 

2022

    

2021

    

(Restated)

    

(Restated)

 

United States

$

(22,391)

$

(20,758)

Foreign

    

 

40

    

 

20

Loss before provision for income taxes

$

(22,351)

$

(20,738)

Current income tax provision is the amount of income taxes reported or expected to be reported on our income tax return. The provision for current income taxes was $19,000 for the years ended March 31, 2022 and March 31, 2021. The current income taxes were related to state income and foreign taxes. The Company did not have current federal income taxes for the fiscal year ended March 31, 2022.

Actual income tax expense differed from the amount computed by applying statutory corporate income tax rates to loss from operations before income taxes. A reconciliation of income tax (benefit) expense to the federal statutory rate follows (in thousands):

Year Ended March 31,

 

2022

    

2021

    

(Restated)

    

(Restated)

 

Federal income tax benefit at the statutory rate

$

(4,694)

$

(4,355)

State taxes, net of federal effect

    

 

(714)

    

 

(327)

Foreign taxes

 

5

 

9

Expiring NOLs and tax credits

11,028

14,086

Impact of state rate change

 

(142)

 

3

Valuation allowance

 

(5,552)

 

(9,483)

Shortfall in tax benefit—stock compensation

 

75

 

87

True-up

(2)

Other

 

13

 

1

Income tax expense

$

19

$

19

The Company’s deferred tax assets and liabilities consisted of the following at March 31, 2022 and 2021 (in thousands):

    

Year Ended March 31,

2022

    

2021

(Restated)

    

(Restated)

Deferred tax assets:

Inventories

$

2,194

$

1,515

Warranty reserve

 

2,513

 

3,135

Bad debt reserve

199

58

Deferred revenue

 

2,284

 

2,358

Net operating loss (“NOL”) carryforwards

 

130,928

 

135,150

Tax credit carryforwards

 

13,370

 

13,988

Depreciation, amortization and impairment loss

 

 

1,237

Lease liability

 

1,464

 

1,146

Interest limitation

 

4,655

 

3,735

Other

 

1,095

 

1,032

Deferred tax assets

 

158,702

 

163,354

Valuation allowance for deferred tax assets

 

(156,702)

 

(162,254)

Deferred tax assets, net of valuation allowance

 

2,000

 

1,100

Deferred tax liabilities:

Depreciation, amortization and impairment loss

 

(594)

 

Right of use assets

 

(1,406)

 

(1,100)

Net deferred tax assets

$

$

Because of the uncertainty surrounding the timing of realizing the benefits of favorable tax attributes in future income tax returns, the Company has placed a valuation allowance against its net deferred income tax assets. The change in valuation allowance for fiscal years ended March 31, 2022 and 2021 was $5.5 million and $9.5 million, respectively.

The Company’s NOL and tax credit carryforwards for federal and state income tax purposes at March 31, 2022 were as follows (in thousands):

Amount

Expiration

    

(Restated)

    

Period

 

Federal NOL generated before April 1, 2018

$

494,213

 

2022 - 2038

Federal NOL generated after March 31, 2018

$

70,613

 

Indefinite

State NOL

$

175,333

 

2025 - 2039

Federal tax credit carryforwards

$

5,713

 

2022 - 2038

State tax credit carryforwards

$

9,692

 

Indefinite

The NOLs and federal and state tax credits can be carried forward to offset future taxable income, if any. Utilization of the NOLs and tax credits are subject to an annual limitation of approximately $57.3 million due to the ownership change limitations provided by the Internal Revenue Code of 1986 and similar state provisions. The federal tax credit carryforward is a research and development credit, which may be carried forward. The state tax credits consist of a research and development credit can be carried forward indefinitely.

Accounting Standards Codification (“ASC”) 740, Income Taxes clarifies the accounting for income taxes by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on management’s evaluation, the total amount of unrecognized tax benefits related to research and development credits as of March 31, 2022 and 2021 was $1.9 million. There were no interest or penalties related to unrecognized tax benefits as of March 31, 2022 or March 31, 2021. The

amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate as of March 31, 2022 and March 31, 2021 was $1.9 million. However, this impact would be offset by an equal increase in the deferred tax valuation allowance as the Company has recorded a full valuation allowance against its deferred tax assets because of uncertainty as to future realization. The fully reserved recognized federal and state deferred tax assets related to research and development credits balance as of March 31, 2022 and 2021 was $5.7 million and $9.7 million, and $6.3 million and $9.7 million, respectively.

A reconciliation of the beginning and ending amount of total gross unrecognized tax benefits is as follows (in thousands):

Balance at March 31, 2020

$

2,272

Gross increase related to prior year tax positions

 

Gross increase related to current year tax positions

 

Lapse of statute of limitations

 

(326)

Balance at March 31, 2021 (Restated)

$

1,946

Gross increase related to prior year tax positions

 

Gross increase related to current year tax positions

 

Lapse of statute of limitations

 

(48)

Balance at March 31, 2022 (Restated)

$

1,898

The Company does not expect a material change to its unrecognized tax benefits over the next twelve months.

The Company files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state, local or non-U.S. income tax examinations by tax authorities for the years before 2016. However, net operating loss carryforwards remain subject to examination to the extent they are carried forward and impact a year that is open to examination by tax authorities. The Company's evaluation was performed for the tax years which remain subject to examination by major tax jurisdictions as of March 31, 2022. When applicable, the Company accounts for interest and penalties generated by tax contingencies as interest and other expense, net in the statements of operations.